CD4 and rheumatoid arthritis: Since, RA pathogenesis is associated to alterations of immune cell functions and cytokine secretion produced in part by pro-inflammatory CD4+ T memory responder cells, a wide variety of bDMARDs have been proposed to target the latter cells.